Marla B. Sultan

4.5k total citations
54 papers, 1.2k citations indexed

About

Marla B. Sultan is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Marla B. Sultan has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 17 papers in Epidemiology and 16 papers in Oncology. Recurrent topics in Marla B. Sultan's work include Amyloidosis: Diagnosis, Treatment, Outcomes (42 papers), Peptidase Inhibition and Analysis (16 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers). Marla B. Sultan is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (42 papers), Peptidase Inhibition and Analysis (16 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers). Marla B. Sultan collaborates with scholars based in United States, United Kingdom and Spain. Marla B. Sultan's co-authors include Balarama Gundapaneni, Jeffrey H. Schwartz, Jane Loftus, Paul P. Lee, Daniel P. Judge, Perry Elliott, Duo Zhou, Terrell A. Patterson, Steven L. Mansberger and Kathleen Ice and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Marla B. Sultan

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marla B. Sultan United States 21 850 313 284 249 233 54 1.2k
Idalina Beirão Portugal 16 436 0.5× 46 0.1× 49 0.2× 94 0.4× 20 0.1× 58 868
Tamer Rezk United Kingdom 16 1.4k 1.6× 6 0.0× 328 1.2× 263 1.1× 145 0.6× 33 1.6k
Chuandi Zhou China 16 292 0.3× 420 1.3× 118 0.4× 12 0.0× 245 1.1× 50 827
Minggao Liang Canada 15 344 0.4× 12 0.0× 59 0.2× 594 2.4× 100 0.4× 18 1.1k
Tami Livnat Israel 20 202 0.2× 200 0.6× 27 0.1× 22 0.1× 197 0.8× 93 1.3k
Yi Shan China 14 231 0.3× 68 0.2× 193 0.7× 72 0.3× 31 0.1× 53 708
J.M.M. Groenewoud Netherlands 18 226 0.3× 712 2.3× 35 0.1× 37 0.1× 452 1.9× 36 1.0k
Cordula Fassbender Germany 16 74 0.1× 87 0.3× 48 0.2× 51 0.2× 77 0.3× 36 592
Masato Kitazawa Japan 13 284 0.3× 59 0.2× 163 0.6× 33 0.1× 32 0.1× 69 689
Eric T. Rush United States 13 386 0.5× 8 0.0× 122 0.4× 181 0.7× 12 0.1× 51 815

Countries citing papers authored by Marla B. Sultan

Since Specialization
Citations

This map shows the geographic impact of Marla B. Sultan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marla B. Sultan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marla B. Sultan more than expected).

Fields of papers citing papers by Marla B. Sultan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marla B. Sultan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marla B. Sultan. The network helps show where Marla B. Sultan may publish in the future.

Co-authorship network of co-authors of Marla B. Sultan

This figure shows the co-authorship network connecting the top 25 collaborators of Marla B. Sultan. A scholar is included among the top collaborators of Marla B. Sultan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marla B. Sultan. Marla B. Sultan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grogan, Martha, Margot K. Davis, María G. Crespo‐Leiro, et al.. (2024). Effect of Long-Term Tafamidis Treatment on Health-Related Quality of Life in Patients with Transthyretin Amyloid Cardiomyopathy. European Journal of Heart Failure. 26(3). 612–615. 4 indexed citations
2.
Witteles, Ronald, John L. Jefferies, Suraj Kapa, et al.. (2024). Atrial Fibrillation as a Prognostic Factor for All-Cause Mortality in Patients With Transthyretin Amyloid Cardiomyopathy. JACC CardioOncology. 6(4). 592–598. 7 indexed citations
3.
Sperry, Brett W., et al.. (2024). Effect of Tafamidis on Renal Function in Patients With Transthyretin Amyloid Cardiomyopathy in ATTR-ACT. JACC CardioOncology. 6(2). 300–306. 9 indexed citations
4.
García‐Pavía, Pablo, Marla B. Sultan, Balarama Gundapaneni, et al.. (2023). Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study. JACC Heart Failure. 12(1). 150–160. 21 indexed citations
5.
Sperry, Brett W., et al.. (2023). EFFECT OF TAFAMIDIS ON RENAL FUNCTION IN PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY IN ATTR-ACT. Journal of the American College of Cardiology. 81(8). 336–336. 2 indexed citations
6.
Shah, Sanjiv J., Nowell M. Fine, Pablo García‐Pavía, et al.. (2023). Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy. JAMA Cardiology. 9(1). 25–25. 35 indexed citations
7.
Li, Hui‐Hua, Mark H. Rozenbaum, Michelle Casey, & Marla B. Sultan. (2022). Estimating the Effect of Tafamidis on Cardiovascular-Related Hospitalization in NYHA Class III Patients with Transthyretin Amyloid Cardiomyopathy in the Presence of Death. Cardiology. 147(4). 398–405. 10 indexed citations
8.
Hanna, Mazen, Nowell M. Fine, Balarama Gundapaneni, Marla B. Sultan, & Ronald Witteles. (2022). Improvements in Efficacy Measures With Tafamidis in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial. JACC Advances. 1(5). 100148–100148. 6 indexed citations
9.
Nativi-Nicolau, José, Daniel P. Judge, James E. Hoffman, et al.. (2021). Natural History and Progression of Transthyretin Amyloid Cardiomyopathy: Insights from ATTR-ACT. ESC Heart Failure. 8(5). 3875–3884. 34 indexed citations
10.
Rapezzi, Claudio, Perry Elliott, Thibaud Damy, et al.. (2020). Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy. JACC Heart Failure. 9(2). 115–123. 76 indexed citations
11.
Damy, Thibaud, Pablo García‐Pavía, Mazen Hanna, et al.. (2020). Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial ( ATTR‐ACT ) and long‐term extension study. European Journal of Heart Failure. 23(2). 277–285. 124 indexed citations
12.
Miller, Alan B., James L. Januzzi, Blair J. O’Neill, et al.. (2020). CAUSES OF CARDIOVASCULAR HOSPITALIZATION AND DEATH IN THE TAFAMIDIS IN TRANSTHYRETIN CARDIOMYOPATHY CLINICAL TRIAL (ATTR-ACT). Journal of the American College of Cardiology. 75(11). 692–692. 2 indexed citations
13.
Hanna, Mazen, Thibaud Damy, Martha Grogan, et al.. (2020). Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial). The American Journal of Cardiology. 141. 98–105. 24 indexed citations
14.
Elliott, Perry, Brian Drachman, Stephen S. Gottlieb, et al.. (2019). 1169Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy. European Heart Journal. 40(Supplement_1). 6 indexed citations
15.
Younus, Muhammad, Ronald A. Schachar, Min Zhang, et al.. (2018). A Long-term Safety Study of Latanoprost in Pediatric Patients With Glaucoma and Ocular Hypertension: A Prospective Cohort Study. American Journal of Ophthalmology. 196. 101–111. 6 indexed citations
16.
17.
Huang, Kui, et al.. (2016). Practice patterns of ophthalmologists administering intravitreal injections in Europe: a longitudinal survey. Clinical ophthalmology. Volume 10. 2485–2488. 23 indexed citations
18.
Sultan, Marla B., Carla Starita, & Kui Huang. (2012). Epidemiology, risk factors and management of paediatric diabetic retinopathy: Table 1. British Journal of Ophthalmology. 96(3). 312–317. 23 indexed citations
19.
Sultan, Marla B., et al.. (2011). A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema. Ophthalmology. 118(6). 1107–1118. 127 indexed citations
20.
Sultan, Marla B., Steven L. Mansberger, & Paul P. Lee. (2009). Understanding the Importance of IOP Variables in Glaucoma: A Systematic Review. Survey of Ophthalmology. 54(6). 643–662. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Idalina Beirão Breakdown of academic impact, for papers by Tamer Rezk Breakdown of academic impact, for papers by Chuandi Zhou Breakdown of academic impact, for papers by Minggao Liang Breakdown of academic impact, for papers by Tami Livnat Breakdown of academic impact, for papers by Yi Shan Breakdown of academic impact, for papers by J.M.M. Groenewoud Breakdown of academic impact, for papers by Cordula Fassbender Breakdown of academic impact, for papers by Masato Kitazawa Breakdown of academic impact, for papers by Eric T. Rush
Rankless by CCL
2026